Peers & Perspectives in Oncology
May 2026
April 2026
March 2026
February 2026
January 2026
December II 2025
December I 2025
November 2025
October 2025
September I 2025
September II 2025
August 2025
July 2025
June I 2025
Volume: 3
June II 2025
May 2025
April 2025
March I 2025
March II 2025
February 2025
January 2025
Volume: 03
Issue: 01
December I, 2024
December II, 2024
November 2024
October II 2024
October I 2024
September 2024
August I, 2024
August II, 2024
Volume: 2
Issue: 12
July 2024
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Gedatolisib for HR+/HER2−, PIK3CA Wild-Type Advanced Breast Cancer
2
Considering Immunotherapy Rechallenge and TILs for Recurrent Mucosal Melanoma
3
B7-H3–Targeted ADC Risvutatug Rezetecan Extends Survival in Small Cell Lung Cancer
4
FDA Grants Traditional Approval to Selpercatinib for RET Fusion-Positive Tumors
5